MEROLA, Elettra
MEROLA, Elettra
MEDICINA, CHIRURGIA E FARMACIA
- Lineeguida AIOM-ITANET “Neoplasie Neuroendocrine gastroenteropancreatiche”; edizione 2015
2015-01-01 Merola, E; Panzuto, F; Campana, D
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS
2010-01-01 Merola, E; F, Panzuto; M, Rinzivillo; S, Festa; R, Valente; C, Bestani; Et, Al
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors
2010-01-01 Merola, E; F, Panzuto; M, Rinzivillo; S, Festa; C, Bestani; R, Valente; Et, Al
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid
2010-01-01 Merola, E; Capurso, G; Campana, D; Panzuto, F; Monarca, B; Tomassetti, P; Delle Fave, G
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status
2011-01-01 Merola, E; F, Panzuto; L, Boninsegna; G, Capurso; M, Rinzivillo; S, Festa; Et, Al
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome
2014-01-01 Panzuto, F; Merola, E; Rinzivillo, M; Partelli, S; Campana, D; Iannicelli, E; Pilozzi, E; Mercantini, P; Rossi, M; Capurso, G; Scarpa, A; Cascinu, S; Tomassetti, P; Falconi, M; Delle Fave, G
Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence
2025-01-01 Dore, Maria Pina; Merola, Elettra; Pes, Giovanni Mario
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting
2023-01-01 Crispino, F; Merola, E; Tasini, E; Cammà, C; di Marco, V; de Pretis, G; Michielan, A.
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis
2017-01-01 Merola, E; Panzuto, F; Delle Fave, G
Appendiceal collision tumors: case reports, management and literature review
2023-01-01 Viel, G; Ciarleglio, Fa; Frisini, M; Marcucci, S; Valcanover, S; Bragantini, E; Barbareschi, M; Mereu, L; Tateo, S; Merola, E; Armelao, F; De Pretis, G; Brolese, M; Decarli, Nl; Brolese, A
Artificial Intelligence as a Safeguard for Clinical Scientific Integrity: A Human–AI Hybrid Model for Medical Peer Review
2026-01-01 Dore, M. P.; Merola, E.; Lasaracina, G.; Pes, G. M.
Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
2025-01-01 Merola, E.; Fanciulli, G.; Pes, G. M.; Dore, M. P.
Artificial Intelligence in Pancreatic Endoscopic Ultrasonography: From Image-Based Diagnosis to Cytopathology
2026-01-01 Merola, Elettra; Sosa Valencia, Leonardo; Pagano, Nico; Dore, Maria Pina; Montanelli, Julieta; Angelis, Claudio De; Badaoui, Abdenor
Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations
2025-01-01 Merola, Elettra; Fanciulli, Giuseppe; Pes, Giovanni Mario; Dore, Maria Pina
ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors
2022-01-01 Merola, E
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence
2022-01-01 Merola, E; Pascher, A; Rinke, A; Bartsch, Dk; Zerbi, A; Nappo, G; Carnaghi, C; Ciola, M; Mcnamara, Mg; Zandee, W; Bertani, E; Marcucci, S; Modica, R; Grützmann, R; Fazio, N; de Herder, W; Valle, Jw; Gress, Tm; Delle Fave, G; de Pretis, G; Perren, A; Wiedenmann, B; Pavel, Me.
Bone metastases from neuroendocrine neoplasms: Resultsof an Italian nationwide survey of natural historyand management
2025-01-01 Fazio, N; Maisonneuve, P; Frezza, Am; Ranallo, N; Ibrahim, T; La Salvia, A; Brizzi, Mp; De Divitiis, C; Tafuto, S; Pusceddu, S; Marconcini, R; Cives, M; Ferrari, C; Campana, D; De Lisi, D; Santini, D; Faggiano, A; Modica, R; Massironi, S; Bianchi, A; Panzuto, F; Antonuzzo, L; Pellegrini, E; Amoroso, V; Puliafito, I; Merola, E; Silvestris, N; Grana, Cm; Spada, F
Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience
2023-01-01 Merola, E; de Pretis, G; Michielan, A
Cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors
2023-01-01 Michielan, A; Crispino, F; de Pretis, N; Sartori, C; Decarli, Nl; de Pretis, G; Merola, E
Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker?
2016-01-01 Merola, E; Delle Fave, G; Blankenstein, O; Wiedenmann, B; Pavel, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| - Lineeguida AIOM-ITANET “Neoplasie Neuroendocrine gastroenteropancreatiche”; edizione 2015 | 1-gen-2015 | Merola, E; Panzuto, F; Campana, D | |
| ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS | 1-gen-2010 | Merola, E; F, Panzuto; M, Rinzivillo; S, Festa; R, Valente; C, Bestani; Et, Al | |
| Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors | 1-gen-2010 | Merola, E; F, Panzuto; M, Rinzivillo; S, Festa; C, Bestani; R, Valente; Et, Al | |
| Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid | 1-gen-2010 | Merola, E; Capurso, G; Campana, D; Panzuto, F; Monarca, B; Tomassetti, P; Delle Fave, G | |
| Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status | 1-gen-2011 | Merola, E; F, Panzuto; L, Boninsegna; G, Capurso; M, Rinzivillo; S, Festa; Et, Al | |
| Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome | 1-gen-2014 | Panzuto, F; Merola, E; Rinzivillo, M; Partelli, S; Campana, D; Iannicelli, E; Pilozzi, E; Mercantini, P; Rossi, M; Capurso, G; Scarpa, A; Cascinu, S; Tomassetti, P; Falconi, M; Delle Fave, G | |
| Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence | 1-gen-2025 | Dore, Maria Pina; Merola, Elettra; Pes, Giovanni Mario | |
| Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting | 1-gen-2023 | Crispino, F; Merola, E; Tasini, E; Cammà, C; di Marco, V; de Pretis, G; Michielan, A. | |
| Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis | 1-gen-2017 | Merola, E; Panzuto, F; Delle Fave, G | |
| Appendiceal collision tumors: case reports, management and literature review | 1-gen-2023 | Viel, G; Ciarleglio, Fa; Frisini, M; Marcucci, S; Valcanover, S; Bragantini, E; Barbareschi, M; Mereu, L; Tateo, S; Merola, E; Armelao, F; De Pretis, G; Brolese, M; Decarli, Nl; Brolese, A | |
| Artificial Intelligence as a Safeguard for Clinical Scientific Integrity: A Human–AI Hybrid Model for Medical Peer Review | 1-gen-2026 | Dore, M. P.; Merola, E.; Lasaracina, G.; Pes, G. M. | |
| Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms | 1-gen-2025 | Merola, E.; Fanciulli, G.; Pes, G. M.; Dore, M. P. | |
| Artificial Intelligence in Pancreatic Endoscopic Ultrasonography: From Image-Based Diagnosis to Cytopathology | 1-gen-2026 | Merola, Elettra; Sosa Valencia, Leonardo; Pagano, Nico; Dore, Maria Pina; Montanelli, Julieta; Angelis, Claudio De; Badaoui, Abdenor | |
| Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations | 1-gen-2025 | Merola, Elettra; Fanciulli, Giuseppe; Pes, Giovanni Mario; Dore, Maria Pina | |
| ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors | 1-gen-2022 | Merola, E | |
| ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence | 1-gen-2022 | Merola, E; Pascher, A; Rinke, A; Bartsch, Dk; Zerbi, A; Nappo, G; Carnaghi, C; Ciola, M; Mcnamara, Mg; Zandee, W; Bertani, E; Marcucci, S; Modica, R; Grützmann, R; Fazio, N; de Herder, W; Valle, Jw; Gress, Tm; Delle Fave, G; de Pretis, G; Perren, A; Wiedenmann, B; Pavel, Me. | |
| Bone metastases from neuroendocrine neoplasms: Resultsof an Italian nationwide survey of natural historyand management | 1-gen-2025 | Fazio, N; Maisonneuve, P; Frezza, Am; Ranallo, N; Ibrahim, T; La Salvia, A; Brizzi, Mp; De Divitiis, C; Tafuto, S; Pusceddu, S; Marconcini, R; Cives, M; Ferrari, C; Campana, D; De Lisi, D; Santini, D; Faggiano, A; Modica, R; Massironi, S; Bianchi, A; Panzuto, F; Antonuzzo, L; Pellegrini, E; Amoroso, V; Puliafito, I; Merola, E; Silvestris, N; Grana, Cm; Spada, F | |
| Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience | 1-gen-2023 | Merola, E; de Pretis, G; Michielan, A | |
| Cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors | 1-gen-2023 | Michielan, A; Crispino, F; de Pretis, N; Sartori, C; Decarli, Nl; de Pretis, G; Merola, E | |
| Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker? | 1-gen-2016 | Merola, E; Delle Fave, G; Blankenstein, O; Wiedenmann, B; Pavel, M |